<DOC>
	<DOCNO>NCT00099801</DOCNO>
	<brief_summary>The safety efficacy FTY720 evaluate patient receive kidney transplant .</brief_summary>
	<brief_title>Safety Efficacy FTY720 Adult Patients Who Receive Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Patients undergo first kidney transplant Male female age 18 65 year Patients need second kidney transplant multiorgan transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Kidney , Transplantation , Rejection , Immunosuppression</keyword>
</DOC>